1. Home
  2. CYTK vs AN Comparison

CYTK vs AN Comparison

Compare CYTK & AN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYTK
  • AN
  • Stock Information
  • Founded
  • CYTK 1997
  • AN 1991
  • Country
  • CYTK United States
  • AN United States
  • Employees
  • CYTK N/A
  • AN N/A
  • Industry
  • CYTK Biotechnology: Pharmaceutical Preparations
  • AN Other Specialty Stores
  • Sector
  • CYTK Health Care
  • AN Consumer Discretionary
  • Exchange
  • CYTK Nasdaq
  • AN Nasdaq
  • Market Cap
  • CYTK 6.0B
  • AN 6.6B
  • IPO Year
  • CYTK 2004
  • AN N/A
  • Fundamental
  • Price
  • CYTK $48.87
  • AN $171.15
  • Analyst Decision
  • CYTK Buy
  • AN Strong Buy
  • Analyst Count
  • CYTK 16
  • AN 9
  • Target Price
  • CYTK $84.07
  • AN $196.00
  • AVG Volume (30 Days)
  • CYTK 1.1M
  • AN 513.4K
  • Earning Date
  • CYTK 11-06-2024
  • AN 02-11-2025
  • Dividend Yield
  • CYTK N/A
  • AN N/A
  • EPS Growth
  • CYTK N/A
  • AN N/A
  • EPS
  • CYTK N/A
  • AN 17.39
  • Revenue
  • CYTK $3,219,000.00
  • AN $26,319,600,000.00
  • Revenue This Year
  • CYTK N/A
  • AN $0.46
  • Revenue Next Year
  • CYTK $795.25
  • AN $2.08
  • P/E Ratio
  • CYTK N/A
  • AN $9.83
  • Revenue Growth
  • CYTK N/A
  • AN N/A
  • 52 Week Low
  • CYTK $43.21
  • AN $133.13
  • 52 Week High
  • CYTK $110.25
  • AN $197.18
  • Technical
  • Relative Strength Index (RSI)
  • CYTK 44.62
  • AN 44.84
  • Support Level
  • CYTK $45.66
  • AN $166.45
  • Resistance Level
  • CYTK $49.40
  • AN $175.15
  • Average True Range (ATR)
  • CYTK 1.71
  • AN 3.80
  • MACD
  • CYTK -0.20
  • AN -1.34
  • Stochastic Oscillator
  • CYTK 50.79
  • AN 19.31

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About AN AutoNation Inc.

AutoNation is the second largest automotive dealer in the United States, with 2023 revenue of about $27 billion and over 250 dealerships, plus 53 collision centers. The firm also has 23 AutoNation USA used-vehicle stores, a captive lender, four auction sites, and three parts distributors all across 21 states primarily in Sunbelt metropolitan areas. New-vehicle sales account for nearly half of revenue; the company also sells used vehicles, parts, and repair services as well as auto financing. The company (formerly Republic Industries) spun off its waste management unit (Republic Services) in 1999 and its car rental businesses (ANC Rental) in 2000. Wayne Huizenga founded the company in the 1990s to bring the rollup acquisition strategy to auto retailing, which has proved to be a smart move.

Share on Social Networks: